Sun Pharma vs Ranbaxy: Competition Law Analysis

This coursework explores the merger between Sun Pharma and Ranbaxy through the lens of competition law. It provides an overview of the companies, analyses key legal concerns, examines regulatory frameworks, and highlights the main findings of the case. The presentation aims to contextualise the legal and economic repercussions for the pharmaceutical industry, offering insights into regulatory practices, compliance, and future implications for market competition.